dentalcorp Holdings Ltd.
DNTL.TOTSXHealthcare
$11.00
+$0.01(+0.09%)
Market Cap$2.1B
P/E Ratio—
52W High$11.02
52W Low$7.1
dentalcorp Holdings Ltd. (DNTL.TO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DNTL.TO · earnings · updated Jun 8, 2026
Latest Earnings
Q4 FY2025Report Date: Nov 6, 2025EPS Actual
-$0.02
Est. $0.11 · -121.8%
Revenue
$0.42B
Est. $0.42B · +0.8%
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Nov 6, 2025
After Market Close
▼ Miss EPS
DNTL.TO reports quarterly as a TSX-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▼ Q4 FY2025 | Nov 6, 2025 | $0.11 | -$0.02 | -121.8% | $0.42B | $0.42B | +0.8% |
| ▼ Q3 FY2025 | Aug 8, 2025 | $0.11 | $0.00 | -96.0% | $0.44B | $0.42B | +4.4% |
| ▼ Q2 FY2025 | May 12, 2025 | $0.14 | $0.10 | -28.6% | $0.41B | $0.44B | -6.6% |
| ▲ Q1 FY2025 | Mar 21, 2025 | $0.12 | $0.14 | +16.7% | $0.40B | $0.40B | -1.8% |
| ▼ Q4 FY2024 | Nov 12, 2024 | $0.10 | $0.03 | -70.0% | $0.38B | $0.40B | -5.4% |
| — Q3 FY2024 | Aug 8, 2024 | $0.12 | $0.12 | +0.0% | $0.40B | $0.37B | +8.8% |
| ▲ Q2 FY2024 | May 10, 2024 | $0.10 | $0.12 | +20.0% | $0.37B | $0.38B | -1.1% |
| ▼ Q1 FY2024 | Mar 22, 2024 | $0.08 | -$0.19 | -334.3% | $0.36B | $0.36B | +0.3% |
Q4 FY2025
Nov 6, 2025Miss
EPS Actual
-$0.02
EPS Est.
$0.11
EPS Surpr.
-121.8%
Revenue
$0.42B
Q3 FY2025
Aug 8, 2025Miss
EPS Actual
$0.00
EPS Est.
$0.11
EPS Surpr.
-96.0%
Revenue
$0.44B
Q2 FY2025
May 12, 2025Miss
EPS Actual
$0.10
EPS Est.
$0.14
EPS Surpr.
-28.6%
Revenue
$0.41B
Q1 FY2025
Mar 21, 2025Beat
EPS Actual
$0.14
EPS Est.
$0.12
EPS Surpr.
+16.7%
Revenue
$0.40B
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
$0.03
EPS Est.
$0.10
EPS Surpr.
-70.0%
Revenue
$0.38B
Q3 FY2024
Aug 8, 2024
EPS Actual
$0.12
EPS Est.
$0.12
EPS Surpr.
+0.0%
Revenue
$0.40B
Q2 FY2024
May 10, 2024Beat
EPS Actual
$0.12
EPS Est.
$0.10
EPS Surpr.
+20.0%
Revenue
$0.37B
Q1 FY2024
Mar 22, 2024Miss
EPS Actual
-$0.19
EPS Est.
$0.08
EPS Surpr.
-334.3%
Revenue
$0.36B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.13 | $0.13 | $0.13 | 1 |
| Q3 FY2026 | $0.14 | $0.14 | $0.14 | 1 |
| Q2 FY2026 | $0.16 | $0.16 | $0.16 | 1 |
| Q1 FY2026 | $0.12 | $0.15 | $0.18 | 2 |
| Q4 FY2025 | $0.17 | $0.17 | $0.17 | 1 |
| Q3 FY2025 | $0.08 | $0.11 | $0.15 | 7 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.5B | $0.5B | $0.5B | 1 |
| Q3 FY2026 | $0.5B | $0.5B | $0.5B | 1 |
| Q2 FY2026 | $0.5B | $0.5B | $0.5B | 1 |
| Q1 FY2026 | $0.4B | $0.4B | $0.4B | 1 |
| Q4 FY2025 | $0.4B | $0.4B | $0.4B | 1 |
| Q3 FY2025 | $0.4B | $0.4B | $0.4B | 11 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q4 FY2025 | Nov 6, 2025 | -121.8% | $10.91 | $10.93 | +0.18% |
| ▼ Q3 FY2025 | Aug 8, 2025 | -96.0% | $8.17 | $8.19 | +0.24% |
| ▼ Q2 FY2025 | May 12, 2025 | -28.6% | $8.81 | $8.93 | +1.36% |
| ▲ Q1 FY2025 | Mar 21, 2025 | +16.7% | $7.45 | $7.77 | +4.30% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -70.0% | $10.32 | $9.89 | -4.17% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +0.0% | $7.45 | $8.20 | +10.07% |
| ▲ Q2 FY2024 | May 10, 2024 | +20.0% | $6.27 | $6.06 | -3.35% |
| ▼ Q1 FY2024 | Mar 22, 2024 | -334.3% | $6.79 | $6.59 | -2.95% |
Q4 FY2025+0.18%
Report Date
Nov 6, 2025
EPS Beat/Miss
-121.8%
Price Before
$10.91
Price After
$10.93
Q3 FY2025+0.24%
Report Date
Aug 8, 2025
EPS Beat/Miss
-96.0%
Price Before
$8.17
Price After
$8.19
Q2 FY2025+1.36%
Report Date
May 12, 2025
EPS Beat/Miss
-28.6%
Price Before
$8.81
Price After
$8.93
Q1 FY2025+4.30%
Report Date
Mar 21, 2025
EPS Beat/Miss
+16.7%
Price Before
$7.45
Price After
$7.77
Q4 FY2024-4.17%
Report Date
Nov 12, 2024
EPS Beat/Miss
-70.0%
Price Before
$10.32
Price After
$9.89
Q3 FY2024+10.07%
Report Date
Aug 8, 2024
EPS Beat/Miss
+0.0%
Price Before
$7.45
Price After
$8.20
Q2 FY2024-3.35%
Report Date
May 10, 2024
EPS Beat/Miss
+20.0%
Price Before
$6.27
Price After
$6.06
Q1 FY2024-2.95%
Report Date
Mar 22, 2024
EPS Beat/Miss
-334.3%
Price Before
$6.79
Price After
$6.59
Avg Beat Reaction+3.67%
Avg Miss Reaction-1.07%
Beat Rate3 / 8 quarters
Largest Move+10.07% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DNTL.TO ends December
dentalcorp Holdings Ltd. (DNTL.TO) most recently reported earnings on November 6, 2025 for Q4 FY2025, posting EPS of $-0.02 — missing the analyst consensus of $0.11 by -121.8%. The next DNTL.TO earnings date is expected around September 1, 2026.
Each quarter, investors track DNTL.TO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DNTL.TO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DNTL.TO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DNTL.TO earnings · 5 questionsdentalcorp Holdings Ltd.'s next earnings report is expected around September 1, 2026. DNTL.TO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DNTL.TO historically reports after market close (AMC).
DNTL.TO earnings datewhen is DNTL.TO earningsDNTL.TO next earnings datewhen does DNTL.TO report earningsDNTL.TO earnings calendar
▸ Source: FMP · dentalcorp Holdings Ltd. SEC filings · US GAAP · dentalcorp Holdings Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026